Skip to main content
Veterinary Medicines

Gynaecologische Obletten 1 g Tablet voor intra-uterien gebruik

Authorised
  • Chlortetracycline hydrochloride

Product identification

Medicine name:
Gynaecologische Obletten 1 g Tablet voor intra-uterien gebruik
Oblets Gynécologiques 1 g Comprimé intra-utérin
Uterus Stäbe 1 g Tablette zur intrauterinen Anwendung
Active substance:
  • Chlortetracycline hydrochloride
Target species:
  • Cattle
Route of administration:
  • Intrauterine use

Product details

Active substance and strength:
  • Chlortetracycline hydrochloride
    1.00
    gram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Intrauterine tablet
Withdrawal period by route of administration:
  • Intrauterine use
    • Cattle
      • Meat and offal
        3
        day
      • Milk
        96
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG51AA08
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • Gynecological Oblets 100 Blister (ALU/PVC) Intrauterine tablet
  • Gynecological Oblets 50 Blister (ALU/PVC) Intrauterine tablet
  • Gynecological Oblets 100 Blister Intrauterine tablet
  • Gynecological Oblets 50 Blister Intrauterine tablet

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • V.M.D.
Marketing authorisation date:
Manufacturing sites for batch release:
  • V.M.D.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 21/03/2022
French (PDF)
Published on: 21/03/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 21/03/2022
French (PDF)
Published on: 21/03/2022
German (PDF)
Published on: 21/03/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."